September 29, 2017
We are pleased to share the Ontario Institute for Cancer Research (OICR) Annual Report for 2016/17.
We are living in an era of unprecedented innovation in cancer research. Recent advances have helped us to better understand cancer and allowed for collaboration on a scale that was previously not possible. This work is happening now and it is happening right here in Ontario.
November 9, 2016
Men newly diagnosed with prostate cancer face a difficult dilemma: either wait and see how the growth develops and whether it is aggressive, or treat it fully right away and risk the many long-term side effects of treatment. Dr. Tamara Jamaspishvili is a young researcher at Queen’s University in Kingston who is working to change that.
November 1, 2016
Evaluating new therapies for cancer through clinical trials is one of the most important steps in moving novel drugs from the lab to clinical use. Recently Dr. Michael Taylor and his collaborators discovered a way to improve clinical trials for testing new therapies for medulloblastoma, a common form of brain cancer in children. The study was conducted with OICR’s support.
October 19, 2016
Prostate cancer is the most common cancer in Canadian men and while it has been the focus of extensive research, an estimated 4,000 Canadians die of the disease each year. That is why six years ago Dr. Paul Boutros and Dr. Rob Bristow set out to sequence the normal and diseased tissue of 350 patients and learn from a clinical perspective how genomic information can be used to guide better treatment.
October 5, 2016
Ontario has some of the finest cancer researchers in the world who are developing new cancer therapies, diagnostic tools and other anti-cancer technologies. When these novel products make their way into clinical use they improve outcomes for cancer patients and reduce the cancer burden on society.
September 27, 2016
We are pleased to share with you the 2015-16 annual report for the Ontario Institute for Cancer Research (OICR).
This year’s report describes the world-class research currently underway at the Institute and details our efforts to bring the fruits of this research to patients in partnership with the Fight Against Cancer Innovation Trust. From new techniques to probe cancer genomes to new partnerships for sharing cancer data securely via the cloud, OICR’s innovations have an impact across the province and around the world.
This report also looks forward to our next five years, as we embark on our new Strategic Plan for 2016-2021. We are confident this new plan will lead to continued research success in the future.
Today OICR’s research supports more than 1,700 investigators, clinician scientists, research staff and trainees across the province of Ontario. These researchers, working with collaborators provincially, nationally and internationally, are making a real impact in the fight against cancer.
We hope you enjoy reading about their work. We welcome any feedback you may have at email@example.com.
Mr. Peter Goodhand
Dr. Lincoln Stein
Interim Scientific Director